Niagen Bioscience, Inc.
SEC 4 · Filed
0001417952-26-000002Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Jun 30, 2026
Grant, award or other acquisition by Fried Robert N
- Security
- Common Stock
- Shares
-
1,106
- Price per share
-
2.71
Structured facts
{
"code": "A",
"date": "2026-06-30",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Shares acquired pursuant to the Issuer\u0027s Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d)."
},
"owners": [
{
"cik": "0001417952",
"name": "Fried Robert N",
"roles": [
"director",
"officer"
],
"title": "Chief Executive Officer"
}
],
"ownership": "D",
"post_shares": "1060087",
"price": "2.71",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "1106",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}